FDA granted accelerated approval to camizestrant, the first cancer therapy that starts when a blood test finds resistance before scans show progression.

Foods Alive recalled organic moringa leaf powder after a supplier's green powder mix tested positive for Salmonella. No illnesses have been reported.

FDA lab testing found dangerously high levels of undeclared yohimbine in two male enhancement supplements sold online for nearly three years.

FDA issued guidance to prevent a shortage of the starter IV nutrition that premature newborns receive after two outsourcing facilities shut down.

New York City announced five Legionella measures after an Upper East Side cluster killed 11 people, including a public cooling tower map.

Lancaster County's coroner ruled that measles caused a six-week-old girl's death as the CDC counted 3,134 US cases, the most since 1991.

A routine invasive approach should not be replaced with a more selective approach in older patients with the most common type of heart attack. This was the main finding of the EVAOLD trial presented in a Hot Line session today at ESC Congress 2026.

A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce breathing difficulties and is as effective as more traditional breathing exercises. The research was presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

Smoking is not social and leads to increased loneliness, according to a large Europe-wide study presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.

Researchers at UT Southwestern Medical Center have identified a key brain signaling pathway that appears to drive the substantial weight gain often associated with clozapine, a widely used antipsychotic medication. The preclinical findings, published in Nature Communications, point to a potential way to reduce the metabolic side effects of this medication, commonly prescribed for patients with treatment-resistant schizophrenia.